Á¦ 1Â÷ ´ëÇÑÇ÷¾×ÇÐȸ Á¤¹ÐÀÇ·á ½ÉÆ÷Áö¾ö : 2023-07-01
±³À°ÀÏÀÚ : 2023-07-01
±³À°Àå¼Ò : ¿¬¼¼¾Ïº´¿ø ¼¾Ï°¨´ç
±³À°ÁÖÁ¦ : Á¦ 1Â÷ ´ëÇÑÇ÷¾×ÇÐȸ Á¤¹ÐÀÇ·á ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 10:00~10:30 TP(Tumor Protein)53ÀÇ ¸ðµç °Í ±èÇö¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 10:30~11:00 AML-MR(AML, myelodysplasia-related) °ü·Ã À¯ÀüÀÚ ÇöȲ ±è¹Ì¿µ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 11:00~11:30 Ç÷¾×¾ÏÀÇ ¾×ü »ý°Ë À̽ÂÅÂ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 11:30~12:00 Ç÷¾×¾Ï NGS(Next Generation Sequencing) ÆÐ³Î°Ë»ç ¼ÛÁÖ¼±(³ì½ÊÀÚÀÇ·áÀç)
±âŸ 07¿ù 01ÀÏ ¼¾Ï°´ç 13:00~13:30 ÈĹßÁÖÀڷμ CART ¼¾ÅÍ ±¸ÃàÀÇ Know-how Á¶Àçö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 13:30~14:00 Ç÷¾×¾Ï¿¡¼ ¼¼Æ÷Ä¡·áÀÇ ÃÖ½ÅÁö°ß Á¶Çö¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ¼¾Ï°´ç 14:00~14:30 ¼¼Æ÷Ä¡·áÁ¦ ÀÓ»ó°æÇè °ÇüÁø(¼¿ïÀÇ´ë)
±âŸ 07¿ù 01ÀÏ ¼¾Ï°´ç 14:45~15:30 Á¤¹ÐÀÇ·á¼¾ÅÍ ¿î¿µ°æÇè ½Å¸çÀº(Àü³²ÀÇ´ë)